Member Info for twix386

Haven't Thermo said they will do 100k tests a month in uk? When that's online and assuming we get tests done rather than just capacity.
Perhaps 100k tests done will be missed but it should be possible when only Thermo would fulfil that.

I guess so too bakky.
I think the testing is a boost. Just need some more detail. Hopefully soonish

Rue the day - that should be

Bakky,

Why do you say you the the day we ever got involved with it - covid testing?

It's not our core but it's still good to have and our SP was languishing prior to it's announcement.

Yes. Be careful of those who appear very knowledgeable but suffer from more mistakes than average. Also those who only talk up to the point of deliberate misleading.

I'd guess late May or early June fwiw

Indeed.

I suspect the earliest illumina platform news to be 2nd week of May but most likely later.

Illumina news probably around a month away imv
Buying back some today on weakness. Looking to add more if we get to 15p.

We really should get further news on covid test soon. The lack of any detail is costing us as imv there's a month before illumina news which MM's can otherwise play with and probably Are!

We don't know basically.

I have sold lots of 50k shares. Sometimes 4 a day (200k) over the last 3 weeks and bought back a fraction on price dips. Too much guess work which may be relevant. With no details still the market will never give credit. Much to come here but only the promise has arrived so far and we have risen for that element already.

TW comment headline....

Then I look at the prick which will burst the Coronavirus testing bubble on AIM. If you own shares in Novacyt (NCYT), Avacta (AVCT) or any of the other Covid test plays watch out!

So what's his reasoning /view?
Always a chance he'll be right one day!

Interestingly the last comment stated banking as shares raced ahead on coronavirus hype.

Woolly enough not to point out the sell tip was around the hype but before the test partnership and big rise. What con artists these guys are but not technically wrong!

HSR email today stated.....
The other win was Yourgene (LSE:YGEN) which we tipped badly at first but where our average down advice meant readers should have made a big overall gain – a gain we advised banking a few weeks ago as the shares raced ahead on Coronavirus hype.

Jeez! Are they forgetting to mention their sell tip at iro 15p after years of calling it wrong just before rising to 23p and never going back that low. Now 19p and rising back up.

HSR said sell just before the latest big rise on Corona virus test partnership. Stunning timming lol

Yes makes a big difference and surely about time we got some details issued on numbers and more info. Details in trading update were non-informative.

Having sold down I am buying back daily.
2X 50k daily buys at each daily fall.

It's always the same story. SP rises and dives on news. We should level off soon with 15p lowest and then prime for next news. Illumina platform due in about 4 to 6 weeks I'd guess. Aimho

Bakky

Don't feed the trolls. Responding when attacked as I did on other bb just pi55es people off. I understand why but take it from me. It's not worth it and nobody cares. Feel the love.

Picked up 50k. Buying back on weakness.

Interesting Stifel Nicolaus Europe Limited are our broker!

Jeez!

Good rec.......
US financial group Stifel issued a ‘buy’ call on Yourgene’s shares after today’s update.

In its latest research note, Stifel said: “Yourgene’s revenues grew 86% in FY20 (12 months to 31 March) to £16.6m, just shy of our £16.9m target, which would have been met and exceeded but for £0.4m of orders in March that fell into FY21 due to COVID-19 transport restrictions.

“Within this, organic growth was very strong at 36%, and growth was consistent across all regions and product offerings. Core NIPT revenues were up 29% to £10.1m, even while the majority of UK and European customers wait to transition to the Illumina-based IONA test, with regulatory approval due in 2Q20.

“So far, COVID-19 appears to be having a limited impact on the business, having been well prepared and the first shipments to support Novacyt’s COVID-19 diagnostic tests have now been made.

“We believe FY20 was a transformational year for a business that is well positioned for the future. Buy.”

Time to buy s few more soon.

Usual. Priced in largely and sellers taking advantage of buy the rumour sell the news.

Nothing to ramp up the price further when it's too of forecast - slightly below and all else awaited.